P18125
Gene name |
Cyp7a1 (Cyp7) |
Protein name |
Cytochrome P450 7A1 |
Names |
24-hydroxycholesterol 7-alpha-hydroxylase, CYPVII, Cholesterol 7-alpha-hydroxylase, Cholesterol 7-alpha-monooxygenase |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:25428 |
EC number |
1.14.14.23: With reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P18125
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P18125-F1 | Predicted | AlphaFoldDB |
1 variants for P18125
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs8152856 | 371 | T>S | No | EVA |
No associated diseases with P18125
1 regional properties for P18125
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| conserved_site | Cytochrome P450, conserved site | 446 - 455 | IPR017972 |
Functions
| Description | ||
|---|---|---|
| EC Number | 1.14.14.23 | With reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| intracellular membrane-bounded organelle | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| 24-hydroxycholesterol 7alpha-hydroxylase activity | Catalysis of the reaction: (24S)-hydroxycholesterol + O2 + reduced = (24S)-7alpha-dihydroxycholesterol + H+ + H2O + oxidized |
| cholesterol 7-alpha-monooxygenase activity | Catalysis of the reaction: cholesterol + NADPH + H+ + O2 = 7-alpha-hydroxycholesterol + NADP+ + H2O. |
| heme binding | Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring. |
| iron ion binding | Binding to an iron (Fe) ion. |
| steroid hydroxylase activity | Catalysis of the formation of a hydroxyl group on a steroid by incorporation of oxygen from O2. |
14 GO annotations of biological process
| Name | Definition |
|---|---|
| bile acid and bile salt transport | The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| bile acid biosynthetic process | The chemical reactions and pathways resulting in the formation of bile acids, any of a group of steroid carboxylic acids occurring in bile. |
| bile acid signaling pathway | The series of molecular signals initiated by bile acid binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| cellular response to cholesterol | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus. |
| cellular response to glucose stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
| cholesterol catabolic process | The chemical reactions and pathways resulting in the breakdown of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. |
| cholesterol homeostasis | Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell. |
| negative regulation of collagen biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
| negative regulation of fatty acid biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids. |
| positive regulation of cholesterol biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. |
| regulation of bile acid biosynthetic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of bile acids. |
| regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| response to ethanol | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| response to organic cyclic compound | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MMTISLIWGI | AVLVSCCIWF | IVGIRRRKAG | EPPLENGLIP | YLGCALKFGS | NPLEFLRANQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| RKHGHVFTCK | LMGKYVHFIT | NSLSYHKVLC | HGKYFDWKKF | HYTTSAKAFG | HRSIDPNDGN |
| 130 | 140 | 150 | 160 | 170 | 180 |
| TTENINNTFT | KTLQGDALCS | LSEAMMQNLQ | SVMRPPGLPK | SKSNAWVTEG | MYAFCYRVMF |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EAGYLTLFGR | DISKTDTQKA | LILNNLDNFK | QFDQVFPALV | AGLPIHLFKT | AHKAREKLAE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| GLKHKNLCVR | DQVSELIRLR | MFLNDTLSTF | DDMEKAKTHL | AILWASQANT | IPATFWSLFQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| MIRSPEAMKA | ASEEVSGALQ | SAGQELSSGG | SAIYLDQVQL | NDLPVLDSII | KEALRLSSAS |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LNIRTAKEDF | TLHLEDGSYN | IRKDDMIALY | PQLMHLDPEI | YPDPLTFKYD | RYLDESGKAK |
| 430 | 440 | 450 | 460 | 470 | 480 |
| TTFYSNGNKL | KCFYMPFGSG | ATICPGRLFA | VQEIKQFLIL | MLSCFELEFV | ESQVKCPPLD |
| 490 | 500 | ||||
| QSRAGLGILP | PLHDIEFKYK | LKH |